Home
About AREV
Pipeline
Pipeline Overview
Therapeutic Human Nutrition
Extraction and Ingredients
Ingredient Processing
Anti-Virals and Phytomedicinalization
Leadership
Management
Scientific Board
Advisory Board
Investors & Media
Media Room
Press Releases
Peer Reviewed Articles
Stock Quote
Investor Alerts
SEDAR Filings
Contact Us
Home
About AREV
Pipeline
Pipeline Overview
Therapeutic Human Nutrition
Extraction and Ingredients
Ingredient Processing
Anti-Virals and Phytomedicinalization
Leadership
Management
Scientific Board
Special Council
Investors & Media
Corporate Presentation
Media Room
Press Releases
Peer Reviewed Articles
Stock Quote
Investor Alerts
SEDAR Filings
Contact Us
Investors
Media Room
In The News
Search News Releases
June 15, 2022
AREV Life Sciences announces acceleration of the clinical development of SUSTAINN, as further predictions of global famine increase demand for Ready to Use Therapeutic Foods (RUTF’s)
May 27, 2022
AREV Life Sciences issues retention warrants
April 21, 2022
AREV Life Sciences Global Corporation announces engagement of TransBIOTech to facilitate preclinical therapeutic pipeline development
April 19, 2022
Brian V. Elliott Joins Arev Life Sciences Global Corporation
April 8, 2022
Kevin Phelps, CPA Appointed Chief Operating Officer of Arev Life Sciences Global Corporation & Warrant Offering
March 10, 2022
AREV Life Sciences enters Into Collaboration Agreement with Richardson Centre for Functional Foods and Nutraceuticals, University of Manitoba
February 23, 2022
AREV Life Sciences Completes Lab and Fungi Fruiting Room Build
February 17, 2022
AREV Life Sciences Advances Developments, New Appointments, and Relationships
January 18, 2022
AREV SAB member Richard Van Breeman PhD publishes landmark study on CoVid19
December 23, 2021
AREV Life Sciences appoints Allan Echino as Director and Denby Greenslade as interim CFO
December 9, 2021
AREV Life Sciences Settles Pending Litigation with Harvey
December 2, 2021
AREV Life Sciences / Absolem JV Receives Extraction Results
November 30, 2021
AREV Acquires Wright & Well Essentials Inc
November 8, 2021
AREV LIFE SCIENCES GLOBAL CORP ANNOUNCES STOCK OPTION GRANT
September 7, 2021
AREV Signs Definitive Collaborative Development Agreement with Voynich Biosciences and Invites Richard van Breemen PhD to SAB REVISED RELEASE first issued July 28, 2021
September 2, 2021
AREV Announces Brian Cameron as Chief Financial Officer
August 13, 2021
AREV Changes their name to AREV Life Sciences Global Corp
July 29, 2021
AREV Signs Definitive Collaborative Development Agreement with Voynich Biosciences and Invites Richard van Breemen PhD to SAB
July 22, 2021
Data Presented at the 11th IAS Conference on HIV Science Supports AREV’s Development of SUS-TAINN™, a Ready-to-Use Therapeutic Food to Treat Global Malnutrition and Starvation
July 6, 2021
AREV Expands Operations to Rochester New York Establishing Wholly Owned U.S. Subsidiary, AREV Life Sciences, Inc.
Previous
Next
Press Releases
Search Press Releases
June 15, 2022
AREV Life Sciences announces acceleration of the clinical development of SUSTAINN, as further predictions of global famine increase demand for Ready to Use Therapeutic Foods (RUTF’s)
May 27, 2022
AREV Life Sciences issues retention warrants
April 21, 2022
AREV Life Sciences Global Corporation announces engagement of TransBIOTech to facilitate preclinical therapeutic pipeline development
April 19, 2022
Brian V. Elliott Joins Arev Life Sciences Global Corporation
April 8, 2022
Kevin Phelps, CPA Appointed Chief Operating Officer of Arev Life Sciences Global Corporation & Warrant Offering
March 10, 2022
AREV Life Sciences enters Into Collaboration Agreement with Richardson Centre for Functional Foods and Nutraceuticals, University of Manitoba
February 23, 2022
AREV Life Sciences Completes Lab and Fungi Fruiting Room Build
February 17, 2022
AREV Life Sciences Advances Developments, New Appointments, and Relationships
January 18, 2022
AREV SAB member Richard Van Breeman PhD publishes landmark study on CoVid19
December 23, 2021
AREV Life Sciences appoints Allan Echino as Director and Denby Greenslade as interim CFO
December 9, 2021
AREV Life Sciences Settles Pending Litigation with Harvey
December 2, 2021
AREV Life Sciences / Absolem JV Receives Extraction Results
November 30, 2021
AREV Acquires Wright & Well Essentials Inc
November 8, 2021
AREV LIFE SCIENCES GLOBAL CORP ANNOUNCES STOCK OPTION GRANT
September 7, 2021
AREV Signs Definitive Collaborative Development Agreement with Voynich Biosciences and Invites Richard van Breemen PhD to SAB REVISED RELEASE first issued July 28, 2021
September 2, 2021
AREV Announces Brian Cameron as Chief Financial Officer
August 13, 2021
AREV Changes their name to AREV Life Sciences Global Corp
July 29, 2021
AREV Signs Definitive Collaborative Development Agreement with Voynich Biosciences and Invites Richard van Breemen PhD to SAB
July 22, 2021
Data Presented at the 11th IAS Conference on HIV Science Supports AREV’s Development of SUS-TAINN™, a Ready-to-Use Therapeutic Food to Treat Global Malnutrition and Starvation
July 6, 2021
AREV Expands Operations to Rochester New York Establishing Wholly Owned U.S. Subsidiary, AREV Life Sciences, Inc.
Previous
Next
Peer Reviewed Articles
Search Peer Reviewed Articles
May 28, 2021
The protective effect of eicosapentaenoic acid-enriched phospholipids from sea cucumber...
Download PDF
May 28, 2021
Medicinal and health benefit effects of functional sea cucumbers
Download PDF
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Leave us your email address and we’ll send you our Investor Alerts newsletter with new AREV news. You can unsubscribe at any time.
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
